S. Turner, S. Fielding, M. Pijnenburg, J. D. Jongste, K. Pike, G. Roberts, H. Petsky, A. Chang, M. Fritsch, T. Frischer, P. Gergen, S. Szefler, F. Vermeulen, R. Vael
{"title":"By how much can exhaled nitric oxide vary over three months in children with stable asthma?","authors":"S. Turner, S. Fielding, M. Pijnenburg, J. D. Jongste, K. Pike, G. Roberts, H. Petsky, A. Chang, M. Fritsch, T. Frischer, P. Gergen, S. Szefler, F. Vermeulen, R. Vael","doi":"10.1183/13993003.congress-2019.pa5419","DOIUrl":null,"url":null,"abstract":"Introduction: Repeated measurements of fractional exhaled nitric oxide (FeNO) may be useful objective measurements in the management of asthma. There is uncertainty in what merits a clinically-relevant change in FeNO. Methods: Individual participant data were obtained from seven randomised controlled trials where FeNO was used to guide asthma treatment. The FeNO values at the start and end of a period of stable asthma were analysed. The median absolute and percentage change in paired FeNO measurements at the start and end of a stable period were determined for individuals with a baseline FeNO of Results: Data were available in 665 children (mean age 13.1, 59%male). When the initial FeNO was Conclusions: These findings support current recommendations for interpretation of what may be a clinically relevant change in a FeNO value of ≤20ppb but for higher values, greater absolute and percentage change in FeNO values should be tolerated before any alteration in treatment is considered.","PeriodicalId":114886,"journal":{"name":"Paediatric asthma and allergy","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Paediatric asthma and allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.congress-2019.pa5419","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Introduction: Repeated measurements of fractional exhaled nitric oxide (FeNO) may be useful objective measurements in the management of asthma. There is uncertainty in what merits a clinically-relevant change in FeNO. Methods: Individual participant data were obtained from seven randomised controlled trials where FeNO was used to guide asthma treatment. The FeNO values at the start and end of a period of stable asthma were analysed. The median absolute and percentage change in paired FeNO measurements at the start and end of a stable period were determined for individuals with a baseline FeNO of Results: Data were available in 665 children (mean age 13.1, 59%male). When the initial FeNO was Conclusions: These findings support current recommendations for interpretation of what may be a clinically relevant change in a FeNO value of ≤20ppb but for higher values, greater absolute and percentage change in FeNO values should be tolerated before any alteration in treatment is considered.